Sector portfolio · VC firm · United States
The Column Group's Biotech portfolio
The Column Group has backed 19 Biotech startups in rounds we track, $1.8B between them, shown by the stage each has reached. The best-funded is Surrozen.
Funding by segment
- Series C and later$755M7
- Stage not reported$332M5
- Series B$598M4
- Series A$137M3
Where they are based
- United States19$1.8B
United StatesFounded
2 without a founding year on record.
Total raised
- Under $1M0
- $1M to $10M1
- $10M to $50M2
- $50M to $250M15
- $250M to $1B1
- $1B and over0
Each dot is a startup: the year it was founded across, the total it has raised up (each line is ten times the one below). Pick a segment to pick it out.
17 of 19 startups shown; the rest have no founding year or amount on record.
- 1 to 2
- 3 to 7
- 8 to 24
- 25 to 99
- 100 and more
- United States19
Startups by country, 1 country in all.
Segment by segment
Series C and later
7 startups · $755M raised
Peloton TherapeuticsPeloton Therapeutics, a biotech company based in Dallas, is involved in discovering and developing novel drugs for cancer treatments.United States$190M- 3B3-V BiosciencesUnited States$146M
Aragon PharmaceuticalsAragon Pharmaceuticals develops therapeutics for the treatment of hormone-resistant cancers such as prostate and breast cancer.United States$122M
Effector TherapeuticsEffector Therapeutics is an early-stage company focused on the discovery and development of small molecule cancer therapeutics.United States$99M
PlexiumPlexium is a biotechnology company based in San Diego, California, founded in 2018.United States$88M- FBFLX BioUnited States$60M
- OORICUnited States$50M
Stage not reported
5 startups · $332M raised
- IDImmune DesignImmune Design develops vaccines and therapeutics for the prevention and treatment of infectious diseases.United States$99M
Ribon TherapeuticsRibon Therapeutics is a biotechnology company focused on the development of therapeutics treatments targeting stress support pathways.United States$90M- IIgenicaIgenica engages in discovery and development of antibody-based therapeutics for the treatment of cancer.United States$88M
Flexus BiosciencesFlexus Biosciences is a biotechnology company based in San Carlos, California, founded in 2013.United States$53M
Carmot TherapeuticsCarmot Therapeutics provides drugs to treat inflammatory, metabolic, and neurological diseases.United States$2.1M
Series B
4 startups · $598M raised
SurrozenSurrozen is a biopharmaceutical that focuses on unlocking the body’s regenerative power to treat injury and disease.United States$258M
Tenaya TherapeuticsTenaya Therapeutics is a developer of novel therapies designed to offer treatment for heart disease.United States$152M
KallyopeKallyope uses the science of gut-brain biology to create medicines that transform human health.United States$95M
GritstoneA Dallas based sales & marketing firm that specializes in face to face engagements.United States$93M
Series A
3 startups · $137M raised
A2 BiotherapeuticsA2 Biotherapeutics is an early-stage biotechnology company that develops medicines for serious illnesses.United States$57M
EscientEscient specializes in providing business strategies, management consulting, and advisory services for various organizations.United States$40M- AAccentUnited States$40M
How this map is made. Every startup here works in Biotech and has raised money in a round we track that names The Column Group as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026.
More portfolio maps
All portfoliosRaising from investors like The Column Group?
Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports.